About Body skin hyperlaxity due to vitamin K-dependent coagulation factor deficiency
Body skin hyperlaxity due to vitamin K-dependent coagulation factor deficiency is a rare disease catalogued by Orphanet (ORPHA:91135). It is associated with the GGCX gene. Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries.
Clinical Trial Eligibility Tips
What to know before applying to Body skin hyperlaxity due to vitamin K-dependent coagulation factor deficiency trials.
Search ClinicalTrials.gov for "Body skin hyperlaxity due to vitamin K-dependent coagulation factor deficiency" or filter by Orphanet code ORPHA:91135 to find disease-specific studies.
Ask your specialist to refer you to a Centre of Expertise — Orphanet lists all accredited centres for this condition worldwide.
Natural history studies and patient registries often enrol before drug trials open — contact the Orphanet patient community first.
Patient Resources
Find recruiting Body skin hyperlaxity due to vitamin K-dependent coagulation factor deficiency trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for Body skin hyperlaxity due to vitamin K-dependent coagulation factor deficiency. Updated daily.